Synmosa Biopharma Corp
TPEX:4114
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Synmosa Biopharma Corp
TPEX:4114
|
TW |
|
I
|
InTiCa Systems SE
XMUN:IS7
|
DE |
|
Safe SA
F:OR9
|
FR |
|
C
|
Compania de Transporte de Energia Electrica en Alta Tension Transener SA
OTC:TRSNF
|
AR |
|
T
|
Tien Liang Biotech Co Ltd
TPEX:4127
|
TW |
|
A
|
At-Tahur Ltd
KAR:PREMA
|
PK |
|
F
|
Falcon Oil & Gas Ltd
LSE:FOG
|
IE |
Dividends
Dividend Yield
Synmosa Biopharma Corp
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Synmosa Biopharma Corp
Payout Ratio
Synmosa Biopharma Corp
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Synmosa Biopharma Corp is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Synmosa Biopharma Corp
| Average Annual Return | 30.11% |
| Standard Deviation of Annual Returns | 58.38% |
| Max Drawdown | -81% |
| Market Capitalization | 16.3B TWD |
| Shares Outstanding | 550 430 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Synmosa Biopharma Corp's latest stock split occurred on Jul 17, 2026
The company executed a 1079-for-1000 stock split, meaning that for every 1000 shares held, investors received 1079 new shares.
Before the split, Synmosa Biopharma Corp traded at 30.7914 per share. Afterward, the share price was about 29.6.
The adjusted shares began trading on Jul 17, 2026. This was stock split number 18 in Synmosa Biopharma Corp's history, following the previous one in Jul 11, 2025.
